Which one is more effective for the preservartion of postoperative ovarian reserve?

Which one is more effective for the preservartion of postoperative ovarian reserve? By Selma Oransay

Although cystectomy is the most preferred treatment of endometrioma, it is still a matter of debate as it may cause a reduction in the quality and number of remaining follicles, especially important for women who are planning to conceive. Anti-Müllerian…

Key Points Lay Summary

Is it the new gold mine for endometriosis: oral GnRH antagonists

Is it the new gold mine for endometriosis: oral GnRH antagonists By Bahar Yuksel

Progestins and combined oral contraceptive pills are the first step hormonal options for women with endometriosis. But the more the use expands the more cases are seen with resistance to progestins. This gave birth to a need for different therapeutic…

Key Points Lay Summary

Pharmacological Therapy for Endometriosis Pain

Pharmacological Therapy for Endometriosis Pain By Eylül GÜN

The negative effects of endometriosis on women’s quality of life are indisputable. Women who suffer from endometriosis might have to deal with problems in many aspects such as psychological, sexual, social, and economic. Pain which is one of the most…

Key Points Lay Summary

Dienogest treatment increases the risk of Endometriosis reoperation rate

Dienogest treatment increases the risk of Endometriosis reoperation rate By Selma Oransay

The common and accepted therapy of endometriosis is surgery, however medical treatment such as nonsteroidal anti-inflammatory drugs, gonadotropin-releasing hormone agonists, oral contraceptives and oral progestins are used for either relieving pain or to prevent recurrences and reoperation. Due to bone loss and…

Key Points Lay Summary

Progestin suppression for endometriosis before IVF

Progestin suppression for endometriosis before IVF By Hale Goksever Celik

“Dienogest is a suitable and safe substitute for GnRHa pretreatment in endometriosis patients”, according to the Khalifa et al., from Egypt. Endometriosis is one of the leading reasons for infertility due to decreased oocyte/embryo quality, fertilizability, tubal function, and aberrant endometrial…

Key Points Lay Summary

The role of hormonal treatment after endometriosis surgery

The role of hormonal treatment after endometriosis surgery By Bahar Yuksel

Postoperative hormonal suppression after endometriosis surgery still does not have a uniform approach. The meta-analysis study conducted by Zakhari et al. aimed to find a significant answer regarding this burden. They analyzed the database systems including MEDLINE, Embase, Cochrane CENTRAL,…

Key Points Lay Summary

Limits of endometrioma surgery in infertility patients - Liselotte Mettler, MD, PhD

Limits of endometrioma surgery in infertility patients - Liselotte Mettler, MD, PhD By Selma Oransay

The removal of endometrioma may affect ovarian reserve because healthy follicles near endometrioma could also be excised during this procedure. Another concern about the ovarian reserve is that it may be already low before the surgery. Anti Mullerian Hormone (AMH)…

Key Points Lay Summary

Hormone Therapy Before Endometriosis Surgery

Hormone Therapy Before Endometriosis Surgery By Yu Yu

Hormonal therapy can be effective for endometriosis, although laparoscopic surgery is required for the frequent drug-resistant symptoms. Laparoscopic surgery can markedly improve endometriosis-associated pain. The administration of GnRH agonist prior to endometriosis laparoscopic surgery may be beneficial to improve surgical…

Key Points Lay Summary

A hope for postoperative symptomatic endometriosis therapy

A hope for postoperative symptomatic endometriosis therapy By Irem Onur

A new chapter in the treatment of symptomatic endometriosis patients may begin since new medical approaches including oral GnRH antagonists, selective progesterone receptor modulators, aromatase inhibitors, and peritoneal immune response modulators are being actively evaluated. To date, there was only…

Key Points Lay Summary

A new trial to reduce the failure of IVF/ICS protocols in severe endometriosis

A new trial to reduce the failure of IVF/ICS protocols in severe endometriosis By Selma Oransay

Kong et al., from the first affiliated hospital of Zhengzhou University, China, recently published this single-blinded, a multicentered and randomized controlled study in the Journal of Reproductive Health, with the aim to find a safer and more effective ovulation induction regimen for patients with…

Key Points Lay Summary

The use of Elagolix in Women with Liver and Kidney Impairments

The use of Elagolix in Women with Liver and Kidney Impairments By Özge Özkaya

Elagolix may be used in women with moderate liver impairment, when necessary, for up to six months at a dose of 150 mg a day, according to a study published in the scientific journal Clinical Pharmacology in Drug Development. The…

Key Points Lay Summary

Best endometriosis articles of the past year.

Best endometriosis articles of the past year.  By Selma Oransay

Dr.Stowall, from the Department of Obstetrics and Gynecology of Methodist Hospital, Dallas, Texas, USA penned this letter and recently published it in the Journal of Obstetrics and Gynecology to show his remarks of importance on four best publications of the…

Key Points Lay Summary

Could Endometriosis Be Caused by Bacteria?

Could Endometriosis Be Caused by Bacteria? By Özge Özkaya

A new concept called the bacterial contamination hypothesis in endometriosis has been proposed for the first time by researchers in Japan. This means that new potential therapies approaches could exist for this condition in addition to the conventional estrogen-suppressing therapies.…

Key Points Lay Summary

Can Ovarian Stimulation Increase Endometrioma Volume?

Can Ovarian Stimulation Increase Endometrioma Volume? By Kasthuri Nair

Seyhan et al. recently published a paper titled “Do endometriomas grow during ovarian stimulation for assisted reproduction? A three-dimensional volume analysis before and after ovarian stimulation” in Reproductive BioMedicine Online. The authors initially believe that ovarian stimulation, often used in…

Key Points Lay Summary

Investigational Medical Therapies for Endometriosis: Current Data and Future Trends. 

Investigational Medical Therapies for Endometriosis: Current Data and Future Trends.  By Dr. Youngran Park

The medical treatment of endometriosis has traditionally relied on hormonal therapies. Because these hormonal therapies preclude fertility or may have unwanted side effects, there is a great need for novel hormonal and non-hormonal medical options. Therefore, this review focuses on…

Key Points Lay Summary

The Most Cost Effective Medical Treatment to Prevent Recurrent Endometriosis

The Most Cost Effective Medical Treatment to Prevent Recurrent Endometriosis By Özge Özkaya

A new study conducted in China found that a class of drugs called Gonadotropin-releasing hormone agonists (GnRH-a) is more cost effective for the treatment of recurrent endometriosis despite the fact that they are more expensive than oral contraceptives. The results…

Key Points Lay Summary

ICSI Outcomes for Laparoscopic Intervention of Endometriosis

 ICSI Outcomes for Laparoscopic Intervention of Endometriosis By Kasthuri Nair

Women with endometriosis can have trouble conceiving and often turn to fertility treatments for help. Guler et al. recently published a paper in Systems Biology in Reproductive Medicine titled “The Impact of laparoscopic surgery of peritoneal endometriosis and endometrioma on…

Key Points Lay Summary

Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist.  

Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist.   By Yu Yu

Taylor et al. presented an exciting recent study in The New England Journal of Medicine. This article reported the results from a multicentre, double-blind, randomized, placebo-controlled phase 3 trials of elagolix for the treatment of endometriosis-associated pain. As women with…

Key Points Lay Summary

Elagolix (ABT-620) for endometriosis pain?

Elagolix (ABT-620) for endometriosis pain? By Yu Yu

Elagolix is an orally active gonadotropin-releasing hormone antagonist that has just recently completed Phase 3 clinical trial for endometriosis-associated pain (NCT01931670). The review article by Alessandro et al in Archives of Gynecology and Obstetrics summarized the current research findings on…

Key Points Lay Summary